Rodman & Renshaw analyst Elemer Piros reiterates Cassava Sciences (NASDAQ:SAVA) with a Buy and maintains $107 price target.
Rodman & Renshaw Reiterates Buy on Cassava Sciences, Maintains $107 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.